[{"id":0,"href":"/docs/content/bioinformatics/sequence_assembly/01.de_novo_assembly/","title":"01.De Novo Assembly","section":"Sequence Assembly","content":"\rWhat is De Novo Assembly?\r#\rDe novo assembly refers to the process of assembling short DNA or RNA sequence reads into longer contiguous sequences (contigs) without the need for a reference genome. This is particularly useful for sequencing novel genomes or species for which no prior reference sequences are available. The challenge in de novo assembly is to accurately piece together millions of short reads into a coherent and complete sequence.\nKey Features of De Novo Assembly\r#\rNo Reference Genome: Unlike reference-based assembly, de novo assembly does not rely on a known reference genome. Instead, the algorithm attempts to reconstruct the full genome from scratch. Reconstruction from Short Reads: De novo assembly algorithms use overlapping short reads to build contigs. These reads may come from various sequencing platforms like Illumina, PacBio, or Oxford Nanopore. Complexity: Assembling long, complex genomes without a reference is computationally expensive and challenging, particularly when the genome is large or contains repetitive regions. Steps in De Novo Assembly\r#\rDe novo assembly typically involves several major steps:\n1. Preprocessing and Quality Control\r#\rBefore assembly begins, it is essential to preprocess the raw sequencing data:\nRead trimming: Remove low-quality sequences, adapter contamination, and short reads. Error correction: Correct sequencing errors (such as single nucleotide polymorphisms or indels) that might result from the sequencing process. Read normalization: Reduce the effect of overrepresented reads, especially in high-coverage datasets. 2. Read Overlap\r#\rThe next step is identifying and aligning overlapping sequences from short reads to form longer contigs. Algorithms look for shared regions between adjacent reads and merge them to create continuous sequences.\n3. Contig Construction\r#\rAfter identifying overlaps, the short reads are grouped into longer contiguous sequences (contigs). These contigs may range from hundreds to thousands of base pairs in length, depending on the sequencing technology and the assembly algorithm.\n4. Scaffolding\r#\rIn this step, contigs are further arranged and ordered into scaffolds using paired-end reads or long-read sequencing technology. Paired-end reads help bridge gaps between contigs and improve the overall assembly.\n5. Polishing\r#\rPolishing refines the contigs and scaffolds by correcting small errors in the assembly. This step is often done using additional reads or long reads (e.g., from PacBio or Oxford Nanopore sequencing) to improve the accuracy of the final assembly.\nAlgorithms for De Novo Assembly\r#\rSeveral algorithms have been developed for de novo assembly. These algorithms vary in their approaches and performance characteristics. Some key algorithms used in de novo assembly include:\n1. Overlap-Layout-Consensus (OLC)\r#\rThe OLC approach is one of the earliest and most common methods for de novo assembly. The basic steps in this algorithm are:\nOverlap: Identify overlapping regions between reads. Layout: Construct a layout where the reads are arranged based on their overlaps. Consensus: Generate a consensus sequence from the layout to create contigs. The OLC algorithm is particularly suited for long-read data, such as PacBio or Oxford Nanopore, due to the ability of long reads to cover large genomic regions and provide good overlap.\n2. De Bruijn Graph\r#\rIn this approach, sequences are broken down into smaller k-mers (subsequences of length k), and a graph is constructed where each vertex represents a k-mer. The edges between vertices represent the overlap between adjacent k-mers in the reads. The graph is then traversed to form contigs.\nDe Bruijn graphs are particularly useful for short-read data (e.g., Illumina sequencing), as short reads can generate a vast number of k-mers that can be efficiently assembled.\nKey Steps in De Bruijn Graph Assembly:\r#\rK-mer extraction: Identify all k-mers (subsequences of length k) from the raw reads. Graph construction: Build a directed graph where each edge represents an overlap between two k-mers. Path reconstruction: Trace paths through the graph to generate contigs. The main advantage of De Bruijn graphs is that they handle repetitive regions and large genomic datasets more effectively than traditional OLC methods.\n3. Greedy Algorithms\r#\rGreedy algorithms work by iteratively finding the best overlap between reads and joining them to form contigs. This approach is simple but may not always provide the best results when dealing with complex genomes or high levels of sequencing errors.\nCommon Software for De Novo Assembly\r#\rThere are numerous tools available for de novo assembly, each with different strengths and weaknesses. Here are some of the most widely used:\n1. SPAdes (St. Petersburg genome assembler)\r#\rAlgorithm: SPAdes is based on the De Bruijn graph algorithm and is one of the most popular tools for de novo assembly. It is optimized for smaller genomes and has been widely used for microbial and viral genome assembly. Key Features: Works well with short-read data from platforms like Illumina. Supports hybrid assembly using both short and long reads. Excellent for single-cell and metagenomic assemblies. Usage: SPAdes is often recommended for bacterial and fungal genomes, as well as for transcriptome assemblies. 2. Velvet\r#\rAlgorithm: Velvet is another tool that uses the De Bruijn graph approach for de novo assembly. It is known for its fast and memory-efficient assembly capabilities. Key Features: Handles high-throughput sequencing data efficiently. Ideal for medium to large genome assembly projects. Supports paired-end reads. Usage: Velvet is widely used in small-to-medium-sized genome sequencing projects, especially when working with high-throughput short-read data. 3. ABySS\r#\rAlgorithm: ABySS also uses the De Bruijn graph approach and is specifically optimized for large genomes, including whole genome sequencing (WGS) projects. Key Features: Can run in parallel on a cluster for faster assembly. Supports large and complex genomes. Allows for the incorporation of long reads (from PacBio, Nanopore) for better scaffold generation. Usage: ABySS is commonly used for sequencing large genomes, such as plant or vertebrate genomes. 4. SOAPdenovo\r#\rAlgorithm: SOAPdenovo employs the De Bruijn graph approach and is designed for efficient large genome assembly. Key Features: High performance for both small and large genomes. Handles high-throughput sequencing data from Illumina and similar platforms. Scaffolding capabilities that use paired-end data to improve assembly accuracy. Usage: SOAPdenovo is used extensively in whole-genome sequencing, especially when working with genomes of varying complexity. 5. Trinity (for RNA-Seq)\r#\rAlgorithm: Trinity is specifically designed for RNA-Seq data and uses a De Bruijn graph-based approach to assemble transcriptomes. Key Features: Tailored for RNA sequencing data. Identifies both known and novel genes and splicing events. Can handle differential expression analysis and isoform discovery. Usage: Ideal for transcriptome assembly, especially when working with non-model organisms or when reference genomes are not available. 6. Flye\r#\rAlgorithm: Flye is optimized for long-read sequencing data (e.g., from PacBio or Oxford Nanopore) and uses an OLC approach combined with graph-based algorithms. Key Features: Excellent for assembling large genomes from long-read data. Capable of handling repeat-rich and complex genomes. Generates high-quality scaffolds and contigs. Usage: Flye is used for genome assembly from long-read sequencing technologies, providing high-quality results with minimal computational requirements. 7. IDBA-UD\r#\rAlgorithm: IDBA-UD uses the De Bruijn graph approach and is specifically designed to assemble metagenomic data. Key Features: Handles ultra-deep sequencing data efficiently. Useful for assembling low-coverage and complex datasets such as metagenomes. Usage: IDBA-UD is widely used for de novo assembly of metagenomic and environmental sequencing projects. Conclusion\r#\rDe novo assembly is a crucial step in genome reconstruction, especially for species with no reference genomes available. The choice of algorithm and software depends on the type of sequencing data (short or long reads), the complexity of the genome, and the specific goals of the assembly project. With continuous advancements in sequencing technologies and assembly algorithms, the accuracy and efficiency of de novo assembly continue to improve, enabling the study of more complex genomes and transcriptomes.\n"},{"id":1,"href":"/docs/content/bioinformatics/sequence_assembly/02.hybrid_assembly/","title":"03.Hybrid Assembly","section":"Sequence Assembly","content":"\rHybrid Assembly in Sequence Assembly\r#\rWhat is Hybrid Assembly?\r#\rHybrid assembly is a sequencing technique that combines the strengths of short-read and long-read sequencing technologies to produce more accurate and complete genome assemblies. By integrating the benefits of both read types, hybrid assembly helps overcome the limitations of using either approach alone.\nAdvantages of Hybrid Assembly:\r#\rShort reads (e.g., from Illumina sequencing) are highly accurate, cost-effective, and allow for high-depth sequencing. However, they struggle with assembling long, repetitive regions of the genome. Long reads (e.g., from PacBio or Oxford Nanopore) are capable of spanning through long repetitive regions and provide better resolution of structural variants, but they typically have higher error rates and lower throughput. How Hybrid Assembly Works\r#\rHybrid assembly typically involves the following steps:\nShort-read Sequencing: High-coverage sequencing is performed using short-read platforms (such as Illumina), providing a precise and accurate set of reads. Long-read Sequencing: Long-read sequencing is performed using technologies such as PacBio or Oxford Nanopore to capture large genomic regions that are hard to assemble with short reads. Assembly Integration: The short and long reads are combined during the assembly process, allowing the short reads to provide accuracy and the long reads to improve the contiguity and completeness of the assembled genome. Benefits of Hybrid Assembly\r#\rImproved Assembly Quality: Hybrid assembly results in better contiguity (longer contigs) and more accurate genome assemblies, especially for complex or repetitive genomes. Better Handling of Complex Regions: Long reads can span long repeat regions, which short-read technologies often fail to resolve. Hybrid assembly helps in capturing these regions, resulting in a more complete assembly. Error Correction: Short reads can be used to correct the error-prone long reads, leading to improved assembly accuracy and fewer gaps. Common Hybrid Assembly Tools and Algorithms\r#\rSeveral software tools and algorithms have been developed for hybrid assembly. These include:\nSPAdes (Hybrid mode): SPAdes is a popular assembler that supports hybrid assembly by combining both short and long reads. The hybrid mode of SPAdes integrates long reads into a short-read assembly, improving the assembly\u0026rsquo;s completeness. Canu: While primarily designed for long-read assembly, Canu can also be used in hybrid assembly by integrating short reads for error correction. Flye: Flye is another tool that is optimized for long-read assembly but can also be adapted for hybrid assembly workflows. MaSuRCA (Maryland Super Read Cabog Assembly): This tool is specifically designed for hybrid assembly and can combine both short and long reads for more accurate and complete genome assembly. Unicycler: Unicycler is a tool for bacterial genome assembly that uses hybrid assembly techniques, combining short-read Illumina data with long-read PacBio or Nanopore data to produce high-quality assemblies. Challenges in Hybrid Assembly\r#\rData Processing Overhead: Hybrid assembly can require significant computational resources due to the need to handle both short and long-read datasets simultaneously. Complexity in Integration: Integrating short and long reads during the assembly process can be challenging, as these reads differ in length, error profiles, and coverage. Ensuring proper alignment and read correction can be complex. Error Propagation: While hybrid assembly aims to correct long-read errors with short-read data, errors can still propagate if the short-read coverage is insufficient or unevenly distributed. Use Cases for Hybrid Assembly\r#\rDe novo genome assembly: Hybrid assembly is particularly useful for assembling complex, non-model genomes, where long repetitive sequences or structural variations are difficult to resolve with short-read data alone. Human Genomics: Hybrid assembly is often used in human genome projects to achieve a more complete assembly, particularly in regions of the genome that are difficult to assemble with short reads alone (e.g., centromeres, telomeres, and other repetitive regions). Metagenomics: Hybrid assembly can improve the assembly of microbial communities in metagenomic studies by combining different sequencing technologies to capture the diversity of genomes present. Conclusion\r#\rHybrid assembly offers a powerful approach to genome assembly, integrating the advantages of both short-read and long-read sequencing technologies. By leveraging the strengths of each read type, hybrid assembly allows for more accurate, complete, and contiguous genome assemblies, making it especially useful for complex genomes and challenging genomic regions.\nHybrid assembly is widely used in various fields such as de novo genome assembly, human genomics, and metagenomics, where a complete and high-quality genome is required. With the advent of more sophisticated algorithms and computational tools, hybrid assembly is becoming an essential technique in modern bioinformatics and genomics research.\n"},{"id":2,"href":"/docs/content/bioinformatics/sequence_assembly/02.reference_guided_assembly/","title":"02.Reference-Guided Assembly","section":"Sequence Assembly","content":"\rWhat is Reference-Guided Assembly?\r#\rReference-guided assembly (also known as reference-based assembly) is a process in which short sequence reads (such as those generated from next-generation sequencing platforms like Illumina) are mapped to a known reference genome to aid in the reconstruction of the genome or transcriptome of the organism of interest. This approach is commonly used when a reference genome is available for the species or a closely related species. It offers faster and more accurate assembly compared to de novo methods, especially for highly repetitive or complex regions.\nKey Features of Reference-Guided Assembly\r#\rRelies on a Reference Genome: A reference genome or a closely related genome serves as the scaffold for aligning and assembling the sequencing reads. Faster and More Accurate: Since the assembly process uses a known genome as a guide, it can be much faster and more accurate than de novo assembly for species with a reference available. Efficient for Small Variants: Reference-guided assembly is particularly effective for detecting small-scale genetic variations, such as single nucleotide polymorphisms (SNPs), insertions, deletions, and structural variants. Limitations: The approach is limited by the quality and completeness of the reference genome. If the reference is incomplete or highly diverged from the sample, the assembly may be less accurate. Steps in Reference-Guided Assembly\r#\rReference-guided assembly typically involves the following steps:\n1. Read Mapping\r#\rThe first step is to align the sequencing reads to the reference genome. This is done using read-mapping algorithms that find the most probable position of each read in the reference genome, considering both sequence similarity and alignment quality.\nMapping Options: Short reads are typically mapped using algorithms that handle large volumes of data efficiently, such as Bowtie2 or BWA. Long reads may require different mapping tools, such as Minimap2. 2. Alignment Filtering and Quality Control\r#\rAfter the reads are mapped to the reference, quality control steps are performed to ensure accurate alignments:\nRemoving Low-Quality Alignments: Reads that map with low confidence (i.e., with too many mismatches or low mapping quality) are filtered out. Duplicate Removal: Duplicate reads (e.g., from PCR amplification) may be removed to avoid over-representation of certain sequences. 3. Contig Construction\r#\rOnce the reads are mapped and filtered, contigs are built by stitching together the aligned reads. This step may involve resolving ambiguities in regions where multiple reads map to repetitive or highly variable regions of the genome.\n4. Variant Calling and Polishing\r#\rIn reference-guided assembly, variant calling is often performed to identify differences between the sample and the reference genome. This includes identifying single nucleotide polymorphisms (SNPs), insertions, deletions, and structural variations.\nPolishing: After variant calling, the assembly may undergo polishing using additional data or more refined algorithms to improve the accuracy of the final assembly, particularly for regions with low coverage. 5. Scaffolding and Gap Filling\r#\rFor genomes with gaps or incomplete regions, scaffolding techniques are employed to order and orient contigs. This process may also include gap filling to try to close any regions that could not be assembled from the mapped reads alone.\nAlgorithms for Reference-Guided Assembly\r#\rThe most common algorithms for reference-guided assembly focus on efficient read mapping and variant detection. Some key algorithms used include:\n1. Burrows-Wheeler Aligner (BWA)\r#\rBWA is one of the most widely used mapping algorithms for aligning short reads to a reference genome. It uses the Burrows-Wheeler Transform (BWT) and is efficient for both large genomes and high-throughput sequencing datasets.\nBWA-MEM: A popular BWA mode for mapping long reads (e.g., from Illumina or PacBio). BWA-backtrack: A mode used for mapping short reads, typically with higher accuracy. BWA works well for read mapping, providing a fast and accurate alignment, making it a core tool for reference-guided assembly.\n2. Bowtie2\r#\rBowtie2 is another widely used read mapper that is optimized for large genomes and high-throughput sequencing data. It uses a Burrows-Wheeler index for efficient read mapping, similar to BWA.\nKey Features: Handles short and long reads efficiently. Provides options for aligning reads to large genomes with varying levels of complexity. Often used for RNA-seq, ChIP-seq, and other high-throughput sequencing data types. 3. Minimap2\r#\rMinimap2 is a long-read mapping tool optimized for high-throughput sequencing data from platforms like PacBio or Oxford Nanopore. It is particularly well-suited for aligning long reads to a reference genome.\nKey Features: Fast and accurate, suitable for aligning long reads with large variations. Ideal for assembling complex or highly repetitive genomes. 4. SAMtools\r#\rSAMtools is a suite of tools used for working with alignment files in the Sequence Alignment/Map (SAM) format. After read mapping, SAMtools can be used for sorting, indexing, and converting SAM/BAM files, as well as for variant calling and filtering.\n5. GATK (Genome Analysis Toolkit)\r#\rGATK is a powerful toolkit primarily used for variant calling and post-processing of sequence data. It is often used after read mapping to identify genetic variants between the sample and the reference genome.\nKey Features: Excellent for detecting SNPs, indels, and structural variants. Offers tools for variant filtration, annotation, and visualization. Common Software for Reference-Guided Assembly\r#\rHere are some common software tools that integrate the reference-guided assembly pipeline, combining read mapping, variant calling, and contig construction:\n1. Genome Analysis Toolkit (GATK)\r#\rGATK is an integrated toolkit from the Broad Institute used for variant discovery in reference-guided assembly. It is particularly useful in genome re-sequencing projects, enabling the identification of genetic differences between a sample and a reference genome.\nKey Features: Supports SNP, indel, and structural variant calling. Provides tools for quality control and data filtering. Requires mapping files (e.g., BAM files) generated from tools like BWA or Bowtie2. 2. Canu (for long-read assemblies)\r#\rCanu is designed for high-accuracy de novo assembly of long-read data, but it also has the ability to perform reference-guided assembly in certain scenarios. It is optimized for long-read data from platforms like PacBio and Nanopore.\nKey Features: Supports hybrid assemblies with both short and long reads. Can integrate with BWA and other tools for read mapping. Often used in large-scale sequencing projects where long-read data is a key component. 3. STAR (for RNA-Seq)\r#\rSTAR is a fast RNA-Seq read aligner designed for mapping reads to a reference genome or transcriptome. It is widely used for RNA sequencing data, enabling reference-guided assembly and variant discovery.\nKey Features: Supports paired-end and single-end read mapping. Generates accurate alignments in a short amount of time. Can handle splice-aware alignments for RNA-Seq data. 4. Cortex (for large-scale variant detection)\r#\rCortex is a software suite that can perform reference-guided assembly and detect structural variants. It is particularly useful in cases where complex structural variants need to be identified from mapped sequencing reads.\nKey Features: Supports large-scale genome sequencing projects. Detects SNPs, indels, and structural variations with high accuracy. Integrates with other tools like GATK for variant analysis. Advantages of Reference-Guided Assembly\r#\rSpeed and Accuracy: Reference-guided assembly is faster and more accurate compared to de novo assembly, especially when the reference genome is high-quality and closely related to the sample. Reduced Computational Requirements: It typically requires less computational power than de novo assembly, as the algorithm only needs to align reads to an existing reference instead of assembling them from scratch. SNP and Variant Detection: Reference-guided assembly is highly effective for detecting SNPs and small-scale genetic variations between the sample and the reference genome. Limitations of Reference-Guided Assembly\r#\rLimited to Known Genomes: This method requires a reference genome, making it unsuitable for novel species or highly divergent genomes. Reference Bias: The accuracy of the assembly is influenced by the quality and completeness of the reference genome. Poor or incomplete references can lead to misassemblies or missed variants. Inability to Handle Large Structural Variants: Reference-guided assembly may struggle with large structural variants (e.g., large insertions or deletions) unless the reference genome has already been annotated for such features. Conclusion\r#\rReference-guided assembly remains a powerful tool for many genomic studies, especially when a high-quality reference genome is available. It is faster, more accurate, and less computationally intensive than de novo assembly, making it ideal for projects where a known genome or a closely related species\u0026rsquo; genome is available. However, its utility is limited when working with\n"},{"id":3,"href":"/docs/content/bioinformatics/sequence_assembly/04.quality_assessment/","title":"Quality Assessment in Sequence Assembly","section":"Sequence Assembly","content":"\rQuality Assessment in Sequence Assembly\r#\rWhat is Quality Assessment in Sequence Assembly?\r#\rQuality assessment in sequence assembly is the process of evaluating the accuracy, completeness, and reliability of assembled genomes or transcriptomes. This step is crucial to ensure that the final assembled sequence accurately represents the target genome and is free from errors, such as misassemblies, gaps, or incorrect bases.\nQuality assessment is typically performed using various metrics, tools, and methods that allow researchers to evaluate the performance of assembly algorithms and determine whether the assembly is suitable for downstream analyses, such as gene annotation, variant calling, or comparative genomics.\nWhy is Quality Assessment Important?\r#\rEnsuring Accuracy: Accurate sequence assemblies are necessary to make valid biological inferences. Misassemblies or incorrect contig joins can lead to erroneous conclusions in downstream analyses.\nAssembly Completeness: Quality assessment ensures that the assembly is complete and that no important regions (such as gene sequences or regulatory regions) are missing.\nAssessing Assembly Tools: Different assemblers may produce assemblies with different levels of accuracy and completeness. Assessing the quality of each assembler’s output allows researchers to choose the best tool for the job.\nFacilitating Downstream Applications: Many downstream applications (like functional annotation, variant calling, and comparative genomics) rely on high-quality assemblies. Low-quality assemblies can undermine the accuracy of these analyses.\nKey Metrics for Assembly Quality\r#\r1. N50/N90 (Contig and Scaffold Metrics)\r#\rN50: The N50 is the length of the shortest contig or scaffold that, when ordered from longest to shortest, accounts for 50% of the total assembly length. It is a measure of assembly continuity; a larger N50 value typically indicates a more contiguous assembly.\nN90: Similar to N50, but it accounts for 90% of the total assembly length. A higher N90 value indicates a more complete and contiguous assembly.\n2. Contig/Scaffold Count\r#\rThe number of contigs or scaffolds in an assembly is an important metric. A low contig count often indicates a more complete assembly with fewer gaps, while a high contig count suggests fragmented assembly. This metric can help evaluate the success of assembly in resolving large genomic regions. 3. Genome Coverage\r#\rGenome coverage measures how well the entire genome is represented in the assembled sequences. This metric is usually reported as the coverage depth, indicating how many times each base has been sequenced. High coverage ensures that all genomic regions are likely to be covered by reads. 4. Base Quality\r#\rBase quality refers to the accuracy of the nucleotides in the assembly. Base errors can occur during sequencing or assembly, so this metric evaluates how likely a base is to be incorrect. A higher base quality indicates a more reliable assembly. 5. GC Content\r#\rGC content is the proportion of guanine (G) and cytosine (C) bases in the assembly. This metric can help assess whether the assembly is representative of the organism’s genome, as abnormal GC content may indicate assembly issues or contamination. 6. Error Rate (Misassemblies and Gaps)\r#\rMisassemblies refer to errors in the sequence assembly, such as incorrect joins of contigs or the placement of repeats. Quality assessment tools often provide estimates of the error rate, helping to identify potential misassemblies. Gaps in the assembly indicate missing regions, which may arise due to repetitive sequences or low coverage. Tools for Quality Assessment\r#\rSeveral software tools are available for quality assessment in sequence assembly. These tools allow users to evaluate multiple metrics and generate reports on the quality of their assembly.\n1. QUAST (Quality Assessment Tool for Genome Assemblies)\r#\rQUAST is one of the most widely used tools for evaluating the quality of genome assemblies. It generates comprehensive reports on various metrics such as N50, contig count, and genome coverage. It can also compare assemblies to a reference genome to identify errors and misassemblies. 2. BUSCO (Benchmarking Universal Single-Copy Orthologs)\r#\rBUSCO is a tool designed to assess the completeness of genome assemblies by evaluating the presence of universal single-copy orthologs (genes that are highly conserved across species). BUSCO provides a metric for how many of the expected genes are present in the assembly, offering a measure of completeness. 3. CheckM\r#\rCheckM assesses the completeness and contamination of microbial genome assemblies. It uses a set of conserved marker genes to calculate the percentage of complete, fragmented, and missing genes in an assembly, making it especially useful for metagenomic studies. 4. FastQC\r#\rWhile typically used for quality control of raw sequencing data, FastQC can also be helpful for quality assessment in assembly pipelines by providing insight into the quality of the reads that were used for assembly. 5. PACA (Pangenome Assembly Completeness Assessment)\r#\rPACA is used to assess the quality of pangenome assemblies by measuring the completeness of the assembly in terms of core and accessory genomes. 6. Longer Read Specific Tools\r#\rTools like NanoPlot and NanoQC provide quality control and quality assessment of long-read data (e.g., from Oxford Nanopore or PacBio), helping to ensure that long reads do not introduce high error rates or gaps during hybrid assembly. Methods of Quality Assessment\r#\rComparative Assessment\nOne approach to quality assessment is to compare the assembly to a reference genome (if available). Tools like QUAST and BUSCO allow for alignment-based assessments of assembly quality, comparing how well the assembly matches known reference sequences or conserved gene sets.\nAlignment to Known Genes or Markers\nFor organisms with well-characterized genomes, you can align the assembled sequences to known gene markers or orthologous genes. This helps assess whether the assembly correctly includes critical genomic regions.\nError Detection and Correction\nAfter assessing the raw quality metrics, tools such as Pilon can be used to correct errors in assemblies. These tools improve the base quality and correct misassemblies by re-aligning short reads to the assembled sequences and identifying discrepancies.\nGap Filling\nGap filling tools, like GapCloser and Sealer, can be employed to fill in gaps in the assembly that are caused by unsequenced regions. These tools can be critical for improving the continuity of draft assemblies.\nConclusion\r#\rQuality assessment is a critical step in the genome assembly process. It ensures that the assembled genome is accurate, complete, and reliable for downstream analyses. By utilizing a variety of metrics and specialized tools such as QUAST, BUSCO, and CheckM, researchers can ensure that their genome assemblies are of high quality and are suitable for various biological analyses.\nEffective quality assessment leads to better decisions about assembly refinement, error correction, and the selection of appropriate tools and methods for genome assembly. Ultimately, it helps ensure that the final assembly accurately reflects the organism\u0026rsquo;s genome and can be used confidently in scientific research.\n"},{"id":4,"href":"/docs/algorithms/Genetic-Algorithm/","title":"Genetic Algorithm","section":"Algorithms","content":"\rGenetic Algorithm\r#\r"},{"id":5,"href":"/docs/algorithms/","title":"Algorithms","section":"Docs","content":"\rContent\r#\r"},{"id":6,"href":"/docs/content/bioinformatics/","title":"Bioinformatics","section":"Docs","content":"\rIntroduction to Bioinformatics\r#\rTable of Content:\r#\rSequence Assembly Sequence Alignment Genomics Epigenomics Transcriptomics Proteomics Microbiomics Metagenomics Phylogenetics Structural Bioinformatics Machine Learning "},{"id":7,"href":"/docs/content/biotechnology/","title":"Biotechnology","section":"Docs","content":"\rBiotechnology\r#\rTable of Content:\r#\rmacromolecules dna_sequencing "},{"id":8,"href":"/docs/content/biotechnology/macromolecules/DNA/","title":"DNA","section":"Macromolecules","content":"\rWhat is DNA?\r#\rDNA (Deoxyribonucleic Acid) is the molecule that contains the instructions an organism needs to develop, live, and reproduce. It carries genetic information crucial for the growth, development, functioning, and reproduction of all living organisms. DNA is found in nearly every cell of an organism, housed in the cell\u0026rsquo;s nucleus (in eukaryotes) or in the cytoplasm (in prokaryotes). In humans, DNA is located in the chromosomes within the nucleus.\nThe Structure of DNA\r#\rDNA is a long molecule made up of subunits called nucleotides. Each nucleotide consists of three components:\nA phosphate group. A sugar molecule (specifically, deoxyribose in the case of DNA). A nitrogenous base. There are four types of nitrogenous bases: Adenine (A) Thymine (T) Cytosine (C) Guanine (G) These nucleotides link together to form long chains, with each chain consisting of a sugar-phosphate backbone. The four nitrogenous bases pair up in a very specific way to form the \u0026ldquo;steps\u0026rdquo; of the DNA double helix:\nAdenine (A) always pairs with Thymine (T). Cytosine (C) always pairs with Guanine (G). This pairing of bases, known as base pairing, is crucial for the formation of the double helix structure and for accurate DNA replication.\nDouble Helix\r#\rThe classic structure of DNA is a double helix — two long strands of nucleotides twisted around each other. The two strands are held together by hydrogen bonds between the complementary bases, A-T and C-G. This structure was first described by James Watson and Francis Crick in 1953, for which they were awarded the Nobel Prize in Physiology or Medicine in 1962, along with Maurice Wilkins.\nThe Function of DNA\r#\rDNA serves as the genetic blueprint for all living organisms, providing the instructions for building proteins, which are responsible for carrying out most of the functions within a cell. Here\u0026rsquo;s how DNA\u0026rsquo;s information is used:\n1. Genetic Information Storage\r#\rDNA stores the instructions for the cell to make proteins. These instructions are written in the form of genes, which are segments of DNA that encode specific proteins or RNA molecules.\n2. Replication\r#\rBefore a cell divides, it must first make an exact copy of its DNA so that each daughter cell receives a complete set of genetic information. The process of DNA replication ensures that the genetic information is accurately copied.\nHelicase unzips the double helix structure. DNA polymerase reads the existing strand and builds the new complementary strand by adding nucleotides. 3. Protein Synthesis\r#\rDNA is involved in protein synthesis through two main processes:\nTranscription: The process in which an RNA copy of a gene is made. Translation: The process in which the RNA is used as a template to build proteins. 4. Mutation and Variation\r#\rChanges in the DNA sequence (mutations) can occur due to various factors like environmental damage, errors during replication, or recombination. Mutations contribute to genetic variation, which is essential for evolution.\nThe Role of DNA in Heredity\r#\rDNA is responsible for heredity, the process by which genetic traits are passed from parents to offspring. The genetic material is inherited through the gametes (sperm and egg cells in humans), which contain half of the genetic material of the parents. When sperm fertilizes an egg, the resulting offspring inherits a combination of genes from both parents, resulting in a unique genetic profile.\nHumans have 46 chromosomes (23 pairs) in each somatic cell, with one set coming from the mother and the other from the father. These chromosomes contain the genes that code for various traits, from eye color to susceptibility to certain diseases.\nDNA and Genetic Diseases\r#\rCertain genetic diseases are caused by mutations in specific genes. For example:\nCystic fibrosis: Caused by mutations in the CFTR gene. Sickle cell anemia: Caused by a mutation in the HBB gene. Huntington\u0026rsquo;s disease: Caused by a mutation in the HTT gene. Genetic testing can identify mutations that lead to these and other genetic disorders, providing valuable information for diagnosis and treatment.\nDNA Sequencing\r#\rDNA sequencing is the process of determining the exact sequence of nucleotides in a DNA molecule. This can provide valuable insights into the genetic makeup of an organism and is essential for many modern biological research techniques, such as:\nGenome sequencing: Mapping out the entire DNA of an organism. Gene expression analysis: Understanding which genes are active under different conditions. Variant discovery: Identifying mutations in the genome. Advances in sequencing technology, such as next-generation sequencing (NGS), have significantly reduced the cost and time required for sequencing, making it a routine part of genomic research and clinical diagnostics.\nApplications of DNA in Biotechnology\r#\rDNA plays a central role in biotechnology, where it is used for a variety of applications:\nGene cloning: Isolating and making copies of genes for study or therapeutic use. Genetic engineering: Modifying an organism’s genome to introduce desirable traits (e.g., genetically modified crops). Gene therapy: Introducing, removing, or altering genetic material within a person\u0026rsquo;s cells to treat or prevent disease. Forensic analysis: DNA profiling is used in criminal investigations to match suspects to crime scenes or to identify individuals in paternity testing. The Future of DNA Research\r#\rDNA research is constantly evolving. Some exciting areas of research include:\nCRISPR-Cas9 gene editing: A revolutionary tool that allows for precise modification of the DNA in living organisms. Synthetic biology: Creating synthetic DNA sequences or even entire synthetic organisms. Personalized medicine: Using an individual’s DNA to tailor medical treatments to their specific genetic makeup. Conclusion\r#\rDNA is the blueprint of life, storing the genetic information that defines an organism. From its structure as a double helix to its involvement in processes like replication, transcription, and translation, DNA is essential to all living organisms. Its role in inheritance and its potential for research and medicine make DNA a critical focus of modern biology and biotechnology.\nBy continuing to study and manipulate DNA, scientists can unlock even more secrets of life, leading to advancements in medicine, agriculture, and understanding the diversity of life on Earth.\n"},{"id":9,"href":"/docs/content/biotechnology/macromolecules/","title":"Macromolecules","section":"Biotechnology","content":"\rMacromolecules\r#\r"},{"id":10,"href":"/docs/content/pharmacology/","title":"Pharmacology","section":"Docs","content":"\rIntroduction to Pharmacology\r#\rTerminologies\r#\rTerms Description Pharmacokinetics The study of how the body affects a drug. Pharmacodynamics The study of how drugs exert their effects on the body. Toxicology The study of adverse effects of drugs. Pharmacogenomics The study of how an individual\u0026rsquo;s genetic makeup influences their response to drugs. What is Pharmacology?\r#\rPharmacology is the study of drugs and their effects on living organisms, which can be subdivided into:\nPharmacokinetics Pharmacodynamics Toxicology Pharmacogenomics Pharmacokinetics\r#\rPharmacokinetics is the study of how the body affects a drug. It involves understanding the processes of absorption, distribution, metabolism, and excretion (ADME) of drugs within the body. Pharmacokinetic parameters help determine the optimal dosing regimen and predict drug concentrations in various tissues over time.\nEven the most promising pharmacologic therapies will fail in clinical trials if the drug is unable to reach its target organ at a concentration sufficient to have a therapeutic effect.\nPharmacodynamics\r#\rPharmacodynamics is the study of how drugs exert their effects on the body. It explores dosage, mechanisms of action, and activity of drugs, including receptor binding, signal transduction pathways, and resulting pharmacological responses.\nToxicology\r#\rToxicology is the study of adverse effects of drugs, chemicals, and other substances on living organisms. It involves assessing the potential toxicity of substances, identifying toxic mechanisms, and determining safe exposure levels.\nPharmacogenomics\r#\rPharmacogenomics is the study of how an individual\u0026rsquo;s genetic makeup influences their response to drugs. It involves identifying genetic variations that affect drug metabolism, efficacy, and toxicity, thereby maximizing efficacy and minimizing adverse reactions.\nReferences:\r#\rADME Pharmacodynamics Brief Description About This Tutorial:\r#\rBiology background not required. Terminologies highlighted with definitions. Practice questions at the end of each section with answers. Learn at your own pace. Visit the reference page to navigate to the page about your drug of interest.\nIntroduction to Pharmacology\r#\rDefinition and Scope\r#\rIntroduce the concept of pharmacology and its importance in healthcare. Discuss the scope, including drug discovery, development, mechanisms of action, and clinical applications. Historical Perspective\r#\rBriefly cover the historical milestones in pharmacology, from ancient remedies to modern drug development. Basic Concepts\r#\rDefine important terms: drug, pharmacokinetics, pharmacodynamics, dose-response relationships, etc. Introduce principles of drug administration and absorption. Pharmacokinetics\r#\rAbsorption\r#\rRoutes of drug administration (oral, parenteral, topical, inhalation, etc.). Factors affecting drug absorption (e.g., bioavailability, first-pass metabolism). Distribution\r#\rDrug distribution within the body (plasma protein binding, tissue penetration). Factors affecting drug distribution (e.g., tissue perfusion, protein binding). Metabolism\r#\rIntroduction to drug metabolism, including phase I and phase II reactions. Factors influencing drug metabolism (e.g., genetic polymorphisms, drug-drug interactions). Excretion\r#\rMechanisms of drug excretion (renal, hepatic, pulmonary, etc.). Factors influencing drug excretion. Pharmacodynamics\r#\rDrug-Receptor Interactions\r#\rIntroduction to receptors and their classification. Mechanisms of drug-receptor interactions (agonists, antagonists, partial agonists, etc.). Signal Transduction\r#\rOverview of cellular signaling pathways affected by drugs. Examples of common signal transduction pathways targeted by drugs (e.g., G protein-coupled receptors, enzyme-linked receptors). Dose-Response Relationships\r#\rIntroduction to dose-response curves. Types of dose-response relationships (linear, sigmoidal, etc.). Potency vs. efficacy. Drug Toxicity and Adverse Effects\r#\rDifferentiate between side effects, adverse effects, and toxicity. Factors influencing drug toxicity (dose, duration of exposure, patient characteristics). Pharmacotherapeutics\r#\rDrug Classes\r#\rClassification of drugs based on therapeutic uses (e.g., analgesics, antibiotics, antihypertensives, etc.). Mechanisms of action and clinical applications of major drug classes. Treatment Guidelines\r#\rEvidence-based approach to pharmacotherapy. Principles of rational drug use and prescribing. Individual Variation in Drug Response\r#\rGenetic factors influencing drug response (pharmacogenomics). Age, sex, and other patient-related factors affecting drug response. Special Topics\r#\rPharmacoeconomics\r#\rIntroduction to pharmacoeconomic principles. Cost-effectiveness analysis, budget impact analysis, etc. Drug Development and Regulation\r#\rOverview of the drug development process. Regulatory aspects (FDA, EMA, etc.) and drug approval procedures. Drug Interactions\r#\rTypes of drug interactions (pharmacokinetic vs. pharmacodynamic). Clinical implications and management of drug interactions. "},{"id":11,"href":"/docs/content/biotechnology/macromolecules/Proteins/","title":"Proteins","section":"Macromolecules","content":"\rWhat are Proteins?\r#\rProteins are complex macromolecules that play a fundamental role in almost every biological process. They are composed of amino acids, which are the building blocks of proteins. Proteins perform a wide range of essential functions in living organisms, including catalyzing biochemical reactions (as enzymes), supporting cellular structures, and facilitating communication between cells.\nProteins are often referred to as the \u0026ldquo;molecular machines\u0026rdquo; of cells because they carry out most of the cell\u0026rsquo;s functions. The sequence and structure of a protein determine its function, making them highly specialized molecules.\nThe Structure of Proteins\r#\rProteins are made up of long chains of amino acids, and their structure is organized at four distinct levels: primary, secondary, tertiary, and quaternary.\n1. Primary Structure\r#\rThe primary structure of a protein is the sequence of amino acids that make up the polypeptide chain. The sequence of amino acids is determined by the gene encoding the protein, which is transcribed into mRNA and translated into a sequence of amino acids at the ribosome.\nThere are 20 different amino acids, each with a unique side chain (R group), and the order of these amino acids in the polypeptide chain defines the protein\u0026rsquo;s specific structure and function.\n2. Secondary Structure\r#\rThe secondary structure refers to the local folding patterns of the polypeptide chain that result from hydrogen bonds between the backbone atoms. The most common secondary structures are:\nAlpha helix: A right-handed spiral coil, stabilized by hydrogen bonds. Beta-pleated sheet: A zig-zag folding pattern, stabilized by hydrogen bonds between strands. These structures form regular patterns within the polypeptide chain and are critical for the overall shape of the protein.\n3. Tertiary Structure\r#\rThe tertiary structure is the three-dimensional shape of the entire polypeptide chain, including the arrangement of secondary structural elements. This structure is stabilized by various interactions, including:\nHydrophobic interactions: Non-polar side chains tend to cluster together in the interior of the protein, away from water. Hydrogen bonds: Between polar side chains and backbone atoms. Ionic bonds: Between positively and negatively charged side chains. Disulfide bridges: Covalent bonds between sulfur atoms in cysteine residues. The tertiary structure is crucial for the protein\u0026rsquo;s function, as it determines the active site of enzymes and the protein\u0026rsquo;s ability to bind to other molecules.\n4. Quaternary Structure\r#\rSome proteins are made up of multiple polypeptide chains, or subunits. The quaternary structure refers to the arrangement of these subunits into a functional protein complex. Hemoglobin, for example, is a tetramer, composed of four subunits that work together to carry oxygen in the blood.\nThe interactions between subunits in the quaternary structure are similar to those that stabilize the tertiary structure, including hydrophobic interactions, ionic bonds, and hydrogen bonds.\nThe Functions of Proteins\r#\rProteins are involved in nearly every aspect of cellular function. Some of the most important functions include:\n1. Enzyme Catalysis\r#\rOne of the most important roles of proteins is to act as enzymes, which catalyze biochemical reactions. Enzymes lower the activation energy required for reactions, making them occur more efficiently. Examples of enzyme functions include:\nDNA polymerase: Catalyzes the synthesis of DNA during cell division. Amylase: Breaks down starch into simpler sugars during digestion. Pepsin: Digests proteins in the stomach. 2. Structural Support\r#\rProteins also provide structural support to cells and tissues. These structural proteins form the scaffolding that maintains the shape of cells and organs. Examples include:\nCollagen: The main structural protein in the extracellular matrix of connective tissues, such as tendons and skin. Keratin: Found in hair, nails, and skin, providing mechanical strength. Actin and Tubulin: Form the cytoskeleton of the cell, providing structure and enabling movement. 3. Transport\r#\rMany proteins are involved in the transport of molecules across cell membranes or within the bloodstream. These proteins ensure that vital molecules reach their proper destinations in the body. Examples include:\nHemoglobin: A protein in red blood cells that carries oxygen from the lungs to tissues and returns carbon dioxide from tissues to the lungs. Ion channels: Proteins embedded in the cell membrane that allow specific ions (such as sodium, potassium, or calcium) to pass through and help maintain cellular homeostasis. 4. Cell Signaling\r#\rProteins also play key roles in cell signaling—the process by which cells communicate with each other and respond to environmental cues. These proteins include:\nReceptors: Proteins on the cell surface or inside the cell that bind to signaling molecules (such as hormones or neurotransmitters), initiating a cellular response. An example is the insulin receptor, which helps regulate glucose levels. G proteins: Act as intermediaries in signaling pathways, transmitting signals from receptors on the cell surface to intracellular target proteins. 5. Immune Response\r#\rProteins are crucial in the body\u0026rsquo;s defense mechanisms against pathogens. These proteins include:\nAntibodies: Proteins produced by the immune system that recognize and neutralize foreign invaders, such as bacteria and viruses. Cytokines: Small proteins involved in cell signaling during immune responses, including inflammation and infection. 6. Gene Regulation\r#\rProteins also play a significant role in regulating gene expression. These regulatory proteins include:\nTranscription factors: Proteins that bind to DNA to either promote or inhibit the transcription of specific genes. Histones: Proteins that help package DNA into nucleosomes and regulate gene accessibility by influencing the structure of chromatin. Protein Synthesis: From DNA to Protein\r#\rThe process of synthesizing proteins from genetic information encoded in DNA involves two major steps: transcription and translation.\n1. Transcription\r#\rIn the nucleus, the information in a gene (a segment of DNA) is transcribed into messenger RNA (mRNA) by the enzyme RNA polymerase. This mRNA serves as a copy of the gene\u0026rsquo;s information, which can be translated into a protein.\n2. Translation\r#\rThe mRNA leaves the nucleus and enters the cytoplasm, where it is read by ribosomes. The ribosome reads the mRNA sequence in sets of three nucleotides, known as codons, and assembles the corresponding amino acids into a growing polypeptide chain. tRNA molecules bring the correct amino acids to the ribosome, matching the mRNA codons with their corresponding amino acids.\nOnce the polypeptide chain is complete, it undergoes folding into its final three-dimensional structure, often assisted by chaperone proteins. This functional protein is now ready to carry out its specific task in the cell.\nProteins and Disease\r#\rDysfunctions or mutations in proteins are responsible for many diseases. Some common examples include:\nCystic fibrosis: Caused by a mutation in the CFTR protein that disrupts ion transport in cells, leading to thick mucus buildup in the lungs and other organs. Sickle cell anemia: Caused by a mutation in the hemoglobin protein, leading to the formation of abnormal red blood cells. Alzheimer\u0026rsquo;s disease: Associated with the accumulation of misfolded amyloid beta proteins that form plaques in the brain. Cancer: Involves mutations in proteins that regulate cell growth and division, such as tumor suppressors (e.g., p53) and oncogenes. Protein Engineering\r#\rProtein engineering is a field of biotechnology that involves designing and modifying proteins for specific applications. This can include improving enzyme efficiency for industrial processes, developing therapeutic proteins, or creating antibodies for disease treatment. Key techniques in protein engineering include:\nSite-directed mutagenesis: Introducing specific mutations into a protein to alter its properties. Protein design: Using computational tools to design novel proteins with desired functions. Directed evolution: Mimicking natural evolution in the laboratory to improve proteins for specific tasks. Conclusion\r#\rProteins are fundamental molecules that support nearly all biological processes, from metabolism to immune response. Their diverse structures allow them to carry out a wide variety of tasks within the cell, making them indispensable for life. Understanding protein structure and function is essential for advancing fields such as biotechnology, medicine, and genetics.\nThe study of proteins continues to be a central focus in molecular biology and biomedical research, with potential applications ranging from drug development to disease treatment and beyond.\n"},{"id":12,"href":"/docs/content/biotechnology/macromolecules/RNA/","title":"RNA","section":"Macromolecules","content":"\rWhat is RNA?\r#\rRNA (Ribonucleic Acid) is a vital molecule in the biology of all living organisms, playing essential roles in the expression of genetic information stored in DNA. While DNA is the primary carrier of genetic information, RNA serves as a temporary copy of the genetic code that can be used to make proteins, regulate gene expression, and carry out other critical functions.\nRNA is similar to DNA, but there are some important differences in structure and function. While DNA is typically double-stranded, RNA is usually single-stranded. In addition, the sugar molecule in RNA is ribose, whereas DNA contains deoxyribose. Lastly, RNA contains the nitrogenous base uracil (U) in place of thymine (T), which is found in DNA.\nThe Structure of RNA\r#\rRNA is composed of nucleotides, the basic building blocks of the molecule. Each nucleotide contains three components:\nA phosphate group. A ribose sugar (as opposed to deoxyribose in DNA). A nitrogenous base. The four nitrogenous bases in RNA are: Adenine (A) Uracil (U) Cytosine (C) Guanine (G) These bases pair in a complementary manner: A pairs with U, and C pairs with G.\nUnlike DNA, which is double-stranded, RNA is usually single-stranded. This structure allows RNA to take on various shapes depending on its function, from a simple linear strand to complex three-dimensional folds.\nTypes of RNA\r#\rThere are several types of RNA, each with distinct roles in cellular processes:\nMessenger RNA (mRNA): mRNA is a temporary copy of a gene\u0026rsquo;s DNA sequence. It carries genetic information from the DNA in the cell\u0026rsquo;s nucleus to the ribosomes in the cytoplasm, where proteins are synthesized. This is the RNA that is directly involved in the process of translation.\nRibosomal RNA (rRNA): rRNA is a structural and functional component of the ribosomes, which are the \u0026ldquo;factories\u0026rdquo; of the cell where protein synthesis occurs. rRNA helps to bind mRNA and tRNA and catalyze the assembly of amino acids into proteins.\nTransfer RNA (tRNA): tRNA helps decode the mRNA sequence into a polypeptide (protein). It carries amino acids to the ribosome, where they are added one by one to form a protein. Each tRNA has an anticodon that pairs with the complementary codon on the mRNA to ensure the correct amino acid is added.\nSmall Nuclear RNA (snRNA): snRNA is involved in the splicing of mRNA. It helps remove introns (non-coding regions) from the precursor mRNA (pre-mRNA) and join exons (coding regions) together to form mature mRNA.\nMicroRNA (miRNA) and Small Interfering RNA (siRNA): These types of RNA play roles in gene regulation. They can bind to mRNA molecules and prevent their translation into proteins, which is known as RNA interference (RNAi).\nLong Non-Coding RNA (lncRNA): lncRNAs do not code for proteins but are involved in regulating gene expression, chromatin remodeling, and other cellular processes.\nThe Function of RNA\r#\rRNA plays several critical roles in cellular functions, from gene expression regulation to catalyzing reactions. Below are the major functions of RNA:\n1. Gene Expression (Transcription and Translation)\r#\rThe central dogma of molecular biology describes the flow of genetic information:\nDNA → RNA → Protein\nTranscription: The process begins in the cell\u0026rsquo;s nucleus, where an mRNA molecule is synthesized from a DNA template. RNA polymerase reads the DNA strand and builds a complementary RNA strand.\nThis mRNA strand carries the genetic code from the DNA to the cytoplasm, where protein synthesis occurs. Translation: The mRNA is read by the ribosome to synthesize a corresponding protein. The ribosome reads the mRNA in sets of three nucleotides (called codons), each of which codes for a specific amino acid. tRNA molecules bring the appropriate amino acids to the ribosome, where they are linked together to form a protein.\n2. Regulation of Gene Expression\r#\rRNA is also involved in regulating the expression of genes. Different types of RNA molecules, such as microRNAs (miRNAs), small interfering RNAs (siRNAs), and long non-coding RNAs (lncRNAs), can bind to mRNA molecules and prevent them from being translated into proteins. This is called RNA interference (RNAi) and is a mechanism of post-transcriptional regulation.\nThese small RNA molecules can:\nSilence specific genes. Control the amount of protein produced by a gene. Prevent mRNA from being translated into protein. 3. Catalytic Activity (Ribozymes)\r#\rSome RNA molecules, called ribozymes, have the ability to catalyze chemical reactions. Ribozymes are RNA molecules that function as enzymes, speeding up biochemical reactions in the cell. For example, rRNA in ribosomes acts as a ribozyme to catalyze the formation of peptide bonds between amino acids during protein synthesis.\n4. RNA Splicing\r#\rIn eukaryotes, the initial RNA transcript (pre-mRNA) often contains both coding regions (exons) and non-coding regions (introns). Before the mRNA can be translated into protein, the introns must be removed, and the exons must be joined together. This process is called RNA splicing, and it is catalyzed by a complex of snRNAs and proteins called the spliceosome.\n5. RNA as a Genetic Material (in Some Viruses)\r#\rWhile DNA is the primary genetic material in most organisms, some viruses, called RNA viruses, use RNA as their genetic material. Examples of RNA viruses include the flu virus, HIV, and coronavirus. In these viruses, the RNA genome is replicated and transcribed to produce viral proteins necessary for the virus to replicate and infect host cells.\nRNA and Disease\r#\rMany diseases are caused by mutations or malfunctions in RNA molecules or the processes involving RNA. Some examples include:\nCancer: Misregulation of RNA molecules such as microRNAs and long non-coding RNAs can lead to abnormal gene expression and contribute to cancer development. Genetic Disorders: Diseases like cystic fibrosis or Duchenne muscular dystrophy are caused by mutations in the RNA products of certain genes. Viral Infections: Many viruses, such as the flu or HIV, rely on RNA for their genetic material, and targeting viral RNA can be a strategy for antiviral drug development. RNA Sequencing (RNA-Seq)\r#\rRNA sequencing (RNA-Seq) is a high-throughput technique used to analyze the transcriptome—the complete set of RNA molecules in a cell at a given time. RNA-Seq allows researchers to:\nQuantify gene expression levels. Identify alternatively spliced transcripts. Discover novel transcripts and RNA molecules. Investigate the effects of mutations on RNA molecules. RNA-Seq has revolutionized genomics and is widely used to study gene expression in a variety of organisms and under different conditions.\nApplications of RNA in Biotechnology\r#\rRNA plays a significant role in biotechnology, particularly in the areas of genetic engineering and gene therapy:\nRNA-based vaccines: mRNA vaccines, like those developed for COVID-19, use mRNA to instruct cells to produce a protein from the virus, triggering an immune response. Gene editing: RNA molecules like guide RNAs in CRISPR-Cas9 systems are used to edit genes at precise locations. RNA interference (RNAi): RNA-based techniques can be used to silence specific genes, providing a powerful tool for studying gene function and potential therapeutic applications. Conclusion\r#\rRNA is a central molecule in cellular biology, playing key roles in gene expression, regulation, catalysis, and even viral infection. Unlike DNA, which stores genetic information, RNA serves as the intermediary that carries out the processes required for translating genetic instructions into functional proteins. The discovery of RNA\u0026rsquo;s diverse roles has opened up many areas of research and has profound implications for medicine, genetics, and biotechnology.\nBy continuing to study RNA and its various functions, scientists can better understand cellular processes and develop innovative therapies for diseases caused by RNA malfunctions or mutations.\n"},{"id":13,"href":"/docs/content/bioinformatics/sequence_assembly/","title":"Sequence Assembly","section":"Bioinformatics","content":"\rWhat is Sequence Assembly?\r#\rSequence assembly refers to the process of piecing together short DNA or RNA sequences (reads) into longer, continuous sequences (contigs or scaffolds). This is a crucial step in genome sequencing projects, where the goal is to reconstruct the original genomic sequence from millions of short reads generated by high-throughput sequencing technologies. Sequence assembly allows researchers to obtain a complete and accurate representation of an organism\u0026rsquo;s genome or transcriptome.\nThe process involves aligning and merging overlapping fragments of DNA to build a longer, continuous sequence, which is then further refined and validated. Sequence assembly is a critical part of genome sequencing, metagenomics, transcriptomics, and other high-throughput sequencing applications.\nTypes of Sequence Assembly\r#\rSequence assembly can be broadly divided into two main types:\n1. De Novo Assembly\r#\rDe novo assembly refers to the process of assembling a sequence without the use of a reference genome. This approach is often used when sequencing organisms for which no reference genome exists. In de novo assembly, the algorithm attempts to find overlapping regions between reads, building longer contiguous sequences step-by-step. It is computationally more demanding because it requires identifying overlaps and assembling the reads from scratch.\nSteps in De Novo Assembly:\r#\rPreprocessing: Removing low-quality reads and trimming adapters. Read Overlap: Identifying regions of overlap between the short reads. Contig Construction: Assembling overlapping reads into longer contiguous sequences (contigs). Scaffolding: Arranging the contigs into larger structures, often with the help of paired-end reads or long-read technologies. 2. Reference-based (or Mapping) Assembly\r#\rReference-based assembly, also known as mapping assembly, is the process of aligning the short reads against a known reference genome. In this approach, the algorithm maps the reads to the reference sequence, and any discrepancies or gaps are identified. This is a faster and more efficient approach than de novo assembly but is only applicable when a reference genome is available.\nSteps in Reference-based Assembly:\r#\rMapping: Aligning the short reads to the reference genome. Realignment: Adjusting the read alignments to account for gaps or mismatches. Variant Calling: Identifying differences between the reference genome and the assembled sequence (such as single nucleotide polymorphisms (SNPs) or indels). This approach is commonly used in resequencing projects, where the goal is to identify genetic variations within an individual or a population compared to a known reference.\nApplications of Sequence Assembly\r#\rSequence assembly is essential in various fields of genomics and bioinformatics:\n1. Genome Sequencing\r#\rIn genome sequencing, sequence assembly is used to reconstruct the genome of an organism from short reads. For example, in whole-genome sequencing (WGS) projects, millions of short DNA sequences are generated, and sequence assembly algorithms are used to piece them together to produce the entire genome.\n2. Transcriptome Sequencing (RNA-Seq)\r#\rIn RNA sequencing (RNA-Seq), sequence assembly is used to assemble the RNA sequences (reads) into full-length transcripts. This allows researchers to identify genes, analyze gene expression levels, and detect alternative splicing events.\n3. Metagenomics\r#\rIn metagenomic sequencing, sequence assembly is used to reconstruct the genomes of microorganisms in environmental samples (such as soil, water, or the human microbiome). Since the organisms in a metagenomic sample may not have reference genomes, de novo assembly is often necessary to identify and annotate the genetic material of the microbial community.\n4. Genome Comparison and Evolutionary Studies\r#\rSequence assembly is used to assemble the genomes of closely related species or individuals, allowing for comparisons to identify genetic differences. This can provide insights into evolutionary processes, adaptation, and population genetics.\n5. Clinical Genomics\r#\rIn clinical genomics, sequence assembly is used to identify mutations or genetic disorders by assembling patient sequences and comparing them with reference genomes. It is commonly used in personalized medicine for the diagnosis and treatment of genetic diseases, cancer, and other conditions.\nChallenges in Sequence Assembly\r#\rWhile sequence assembly is a powerful tool, it comes with several challenges:\n1. Read Length and Coverage\r#\rThe length of sequencing reads and the depth of coverage are crucial factors in the assembly process. Shorter reads often result in more fragmented assemblies, while longer reads provide better overlap and more accurate assemblies. Insufficient coverage can also lead to gaps or incomplete assemblies.\n2. Repetitive Regions\r#\rMany genomes contain repetitive sequences, which are difficult to assemble because short reads may not provide enough unique information to distinguish between similar sequences. Repetitive regions can lead to misassemblies or gaps in the final genome assembly.\n3. Quality Control\r#\rLow-quality reads, sequencing errors, and adapter contamination can introduce noise into the assembly process. Careful quality control steps, such as read filtering, trimming, and error correction, are necessary to ensure a high-quality assembly.\n4. Computational Complexity\r#\rSequence assembly requires significant computational resources, especially for de novo assembly. As the genome size or the number of reads increases, the computational complexity and memory requirements for assembly algorithms also increase.\n5. Contig Orientation and Scaffolding\r#\rAfter assembling contigs, determining their correct orientation and ordering in relation to one another (scaffolding) can be challenging, especially for large genomes. Paired-end reads and long-read sequencing technologies can help overcome this challenge by providing additional information about the distances between contigs.\nTechnologies and Tools for Sequence Assembly\r#\rSeveral tools and algorithms are available for sequence assembly, each with its own strengths and weaknesses. Some popular tools for de novo and reference-based assembly include:\n1. De Novo Assembly Tools\r#\rSPAdes: A widely used tool for assembling short DNA reads, particularly for smaller genomes. VELVET: A tool designed for genome assembly from short reads, optimized for large-scale sequencing projects. ABySS: A tool that uses a parallel algorithm for de novo assembly of large genomes from short reads. SOAPdenovo: A genome assembler designed for large genomes, offering high accuracy and efficiency. 2. Reference-based Assembly Tools\r#\rBWA (Burrows-Wheeler Aligner): A fast and efficient aligner for mapping short reads to a reference genome. Bowtie2: A popular aligner for short-read mapping, particularly useful for high-throughput sequencing. SAMtools: A suite of tools for working with sequence alignment data, including variant calling and manipulation of aligned sequences. 3. Hybrid Assembly Tools\r#\rMaSuRCA: A hybrid assembler that can combine short and long reads to produce more accurate assemblies. Flye: A tool for assembling long-read data (e.g., from PacBio or Oxford Nanopore) with high accuracy. 4. Quality Control and Preprocessing Tools\r#\rFastQC: A quality control tool for evaluating the quality of sequencing reads. Trimmomatic: A tool for trimming and filtering reads to remove low-quality bases and adapter sequences. Conclusion\r#\rSequence assembly is a critical step in many bioinformatics and genomics workflows, allowing researchers to reconstruct genomes, transcriptomes, and metagenomes from short sequencing reads. It enables the study of genetic variation, gene expression, and microbial diversity, among other applications. As sequencing technologies continue to evolve, improvements in assembly algorithms, quality control, and computational efficiency will further enhance the accuracy and utility of sequence assembly for scientific discovery and clinical applications.\n"},{"id":14,"href":"/docs/content/pharmacology/general_abbreviations/","title":"General_abbreviations","section":"Pharmacology","content":"\rCommon Abbreviations\r#\rCommon Abbreviations in Prescriptions\r#\rHave you ever wondered what the weird abbreviations like \u0026ldquo;p.o\u0026rdquo; or \u0026ldquo;p.e\u0026rdquo; mean? These are, in fact, common abbreviations used in prescriptions to help pharmacologists prepare the drugs and instructions you see when you get your medications.\nHere is a handy list of commonly used abbreviations. Note that these terms might or might not be used and will depend on how the professionals are trained:\nAbbreviation Description AA Of each (ana) AAU Both ears (auris utraque) AC Before meals (ante cibum) AM In the morning (ante meridiem) AD Right ear (auris dexter) AD US Up to (ad usque) AQ Water (aqua) AS Left ear (auris sinister) ATC Around the clock BB By mouth (per os) BID Twice a day (bis in die) BM Bowel movement (bucco-masseteric) C With (cum) CAPS Capsules CONC Concentrated DIL Dilute DIV Divide EC Enteric coated EOD Every other day FT Make, prepare (fac, fiat) GT Drops (guttae) H Hour (hora) HS At bedtime (hora somni) IN Intranasal (intra nasal) IM Intramuscular (intra muscular) IV Intravenous (intra venous) M Mix (misce) M ET N Half and half (misce et nota) MIXT Mixture NON REP Do not repeat (non repetatur) OD Once daily (omni die) OD Right eye (oculus dexter) OS Left eye (oculus sinister) OU Both eyes (oculi utroque) PC After meals (post cibum) PID Twice a day (post in die) PRN As needed (pro re nata) Q Every (quaque) QH Every hour (quaque hora) QHS Every night at bedtime (quaque hora somni) QID Four times a day (quater in die) SL Sublingual (sub lingual) SS One-half (semis) STAT Immediately (statim) TAB Tablet TID Three times a day (ter in die) "},{"id":15,"href":"/docs/content/pharmacology/general_history/","title":"General_histroy","section":"Pharmacology","content":"\rHistory of Pharmacology\r#\rThe field of pharmacology has a rich history that spans thousands of years, reflecting humanity\u0026rsquo;s quest to understand and manipulate the effects of drugs on the body. This tutorial will explore key milestones and developments in the history of pharmacology.\nAncient Practices\r#\rPharmacology can be traced back to ancient civilizations, where herbal remedies were used to treat various ailments. Early records from ancient Egypt, China, and India describe the use of plants and minerals in medicinal preparations. The Ebers Papyrus (circa 1550 BCE) from Egypt is one of the oldest medical texts, listing numerous remedies derived from plants.\nThe Greeks and Romans\r#\rThe Greeks made significant contributions to the field, with philosophers such as Hippocrates (circa 460–370 BCE) emphasizing the importance of observing the effects of substances on the human body. Galen (circa 129–216 CE), a Roman physician, further advanced pharmacology by conducting experiments and establishing principles of drug action based on the four humors theory.\nThe Middle Ages\r#\rDuring the Middle Ages, the study of pharmacology stagnated in Europe but flourished in the Islamic world. Scholars like Avicenna (Ibn Sina) wrote influential texts, such as \u0026ldquo;The Canon of Medicine,\u0026rdquo; which compiled knowledge on herbs and drugs and emphasized the importance of empirical observation.\nThe Renaissance\r#\rThe Renaissance sparked renewed interest in science and medicine, leading to the establishment of botanical gardens and the systematic study of plants for medicinal purposes. Paracelsus (1493–1541) revolutionized pharmacology by advocating the use of chemicals in medicine and emphasizing the concept of dose-response.\nThe 18th and 19th Centuries\r#\rThe 18th century saw the emergence of modern chemistry, paving the way for the isolation of active ingredients from plants. In the 19th century, the discovery of morphine (from opium) and quinine (from cinchona bark) marked significant advancements in the understanding of drug actions and their therapeutic uses.\nThe 20th Century and Beyond\r#\rThe 20th century witnessed explosive growth in pharmacology, driven by advancements in biochemistry and molecular biology. The development of synthetic drugs, antibiotics, and vaccines transformed medicine. Regulatory agencies, such as the FDA, were established to ensure drug safety and efficacy.\nToday, pharmacology continues to evolve with innovations in pharmacogenomics, biotechnology, and personalized medicine, offering new insights into drug actions and individual responses to treatment.\nConclusion\r#\rThe history of pharmacology is a testament to humanity\u0026rsquo;s enduring quest for knowledge and healing. Understanding this history helps us appreciate the complexity of drug interactions and the ongoing advancements in the field.\nFeel free to add more sections or details as needed!\n"},{"id":16,"href":"/docs/content/pharmacology/general_medication_origin/","title":"General_medication_origin","section":"Pharmacology","content":"\rMedication Sourcing and Origins\r#\rSources of Medication\r#\rIn modern medicine, medication refers to the active ingredient or one specific chemical exerting effect on our body. These are often purified from natural sources and through the study of such compounds, more efficacious synthetic forms are created.\nIn general, sources of modern medicine can be divided into:\nNatural Derivatives Semi-Synthetic Synthetic Natural Source of Medication\r#\rPlant Derivatives\r#\rThe use of medicinal plants can date back to ancient Sumeria (3,000 BC), where hundreds of medicinal plants are listed on clay tablets. Although ancient people didn\u0026rsquo;t understand the mechanisms behind them, our ancestors learned to use these plants for curing diseases.\nSince the 19th century, active compounds in these plants have been constantly discovered and purified to create what we now know as medicine. Some well-known plant-derived drugs include:\nMorphine: derived from the opium poppy (Papaver somniferum), used as a pain reliever. Aspirin: originally derived from willow bark, used as a pain reliever and anti-inflammatory agent. Quinine: derived from the bark of the cinchona tree, used to treat malaria. Digitalis: derived from the foxglove plant, used to treat heart conditions. Animal Derivatives\r#\rWith advancements in modern medicine and an understanding of physiology, some well-understood compounds derived from animals are also used as medication. For example:\nInsulin: originally extracted from the pancreas of pigs and cows, used to treat diabetes. Heparin: derived from the mucosal tissues of pigs and cows, used as an anticoagulant. Conotoxins: derived from the venom of cone snails, used as pain relievers and in neurological research. Microorganism-Derived Drugs\r#\rStudies of microorganisms such as bacteria, fungi, and algae have also allowed us to identify a variety of bioactive compounds, mostly for the use of antibiotics. Examples include:\nPenicillin: derived from the fungus Penicillium, used as an antibiotic. Streptomycin: derived from the bacterium Streptomyces, used as an antibiotic. Cyclosporine: derived from a fungus found in Norwegian soil, used as an immunosuppressant. Artemisinin: derived from the sweet wormwood plant, used as an antimalarial. Semi-Synthetic Compounds\r#\rSome drugs are derived from natural sources but undergo chemical modification to improve their properties. Examples include:\nMorphine derivatives: such as codeine and oxycodone, which are semi-synthetic opioids used as pain relievers. Penicillin derivatives: such as amoxicillin and ampicillin, which are semi-synthetic antibiotics derived from the natural compound penicillin. Statins: such as lovastatin and atorvastatin, which are semi-synthetic cholesterol-lowering drugs derived from natural compounds found in fungi. Synthetic Compounds\r#\rMany drugs are synthesized through chemical reactions in laboratories. Examples include:\nAcetaminophen (paracetamol): used as a pain reliever and fever reducer. Albuterol: used as a bronchodilator to treat asthma and chronic obstructive pulmonary disease (COPD). Simvastatin: used to lower cholesterol levels in the treatment of hyperlipidemia. Metformin: used to treat type 2 diabetes by lowering blood sugar levels. References\r#\rInsert references here if needed.\n"},{"id":17,"href":"/docs/content/pharmacology/general_regulations/","title":"General_regulations","section":"Pharmacology","content":"\rClassification of Drugs By Law\r#\rDrug Classification\r#\rIn general, drugs used in healthcare can be classified into four groups by law, including Over-the-Counter (OTC) drugs, prescription drugs, and illegal drugs, ranked from low to high regulation levels.\nClass Legal Status Examples Over-the-Counter (OTC) Drugs Available for purchase without a prescription. Pain relievers, antacids, allergy medications. Prescription Drugs Available only with a prescription from a licensed healthcare professional. Antibiotics, antidepressants, opioids. Illegal Drugs Prohibited by law for recreational use, sale, or possession. Heroin, LSD, marijuana (in some jurisdictions). OTC Drugs\r#\rDrugs labeled as OTC are generally used for common ailments, chronic conditions, preventive care, first aid, and dietary supplements.\nCurrent Use\r#\rCommon Ailments: OTC drugs are commonly used to alleviate symptoms of minor ailments such as headaches, colds, coughs, allergies, and indigestion. Common examples include acetaminophen (Tylenol®), ibuprofen (Advil®), and aspirin.\nChronic Conditions: Some OTC drugs are also used for managing chronic conditions like acid reflux, joint pain, and allergies, providing relief for recurring symptoms. Examples include loratadine (Claritin®) and cetirizine (Zyrtec®) for allergies, as well as bismuth (Pepto-Bismol®) for acid reflux.\nPreventive Care: Certain OTC drugs, such as multivitamins, supplements, and contraceptives, are used for preventive care, helping individuals maintain their health and well-being.\nFirst Aid: OTC drugs like pain relievers, antiseptics, and adhesive bandages are essential components of first-aid kits, used to treat minor injuries and wounds.\nDietary Supplements: Many people use OTC dietary supplements to complement their diets, aiming to address nutritional deficiencies or support specific health goals.\nOTC drugs provide convenient access to medications, allowing individuals to quickly address minor health concerns without the need for a prescription or a visit to a healthcare provider. However, due to their accessibility and cost-effectiveness, misuse and addiction have become major concerns for OTCs, as described by Schifano et al., 2021. According to the review, misuse most often occurs in patients already suffering from health conditions or psychiatric disorders, with cough mixtures containing dextromethorphan (DXM), codeine, and nasal decongestants containing pseudoephedrine being common sources of misuse.\nIt is also important to note that these medications can still have side effects, even though they are generally considered safe. For example, nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or aspirin can increase the risk of heart attack, stroke, or gastrointestinal bleeding, especially with long-term or high-dose use.\nPrescriptions\r#\rPrescription drugs are typically more potent and specialized but may also be more harmful or addictive than over-the-counter (OTC) drugs. In North America, ℞, usually printed as \u0026ldquo;Rx,\u0026rdquo; is used as an abbreviation for the word \u0026ldquo;prescription.\u0026rdquo; Therefore, a prescription from a licensed healthcare provider, such as a physician, nurse practitioner, or dentist, is required. These medications are regulated by government agencies to ensure their safety, efficacy, and proper use.\nA major concern in this class of drugs is antibiotic resistance, which refers to the ability of pathogens (organisms that we want to kill) to gain resistance through the misuse or overuse of antibiotics. The exact mechanisms behind antibiotic resistance are complex, and we will discuss it later in this tutorial. In general, to reduce antibiotic resistance, it is important for patients to complete the full course of antibiotics as prescribed.\nIllegal Drugs\r#\rIllegal drugs are often highly addictive and harmful to the body and are not commonly used for the treatment of diseases due to their side effects greatly outweighing their benefits. The definition and list of illegal drugs vary between countries, and some drugs classified as illegal may actually be available by prescription in others. Common illegal drugs include 3,4-methylenedioxymethamphetamine (MDMA), gamma-Hydroxybutyric acid (GHB), and phencyclidine (PCP).\nPharmacopeia Websites\r#\rPharmacopeia refers to an official publication containing a list of medicinal drugs with their effects and directions for their use. Depending on the country, pharmacopeia can be found on different government websites:\nCountry Pharmacopeia United States United States Pharmacopeia (USP) Europe European Pharmacopoeia (Ph. Eur.) United Kingdom British Pharmacopoeia (BP) Japan Japanese Pharmacopoeia (JP) India Indian Pharmacopoeia (IP) China Chinese Pharmacopoeia (ChP) France French Pharmacopoeia (Pharmacopée Française) Germany German Pharmacopoeia (Deutsches Arzneibuch, DAB) Russia Russian Pharmacopoeia (Pharmacopoea Rossica) Brazil Brazilian Pharmacopoeia (Farmacopeia Brasileira) Australia Australian Medicines Handbook (AMH) References\r#\rSchifano, F., Chiappini, S., Miuli, A., Mosca, A., Santovito, M. C., Corkery, J. M., Guirguis, A., Pettorruso, M., Di Giannantonio, M., \u0026amp; Martinotti, G. (2021). Focus on Over-the-Counter Drugs\u0026rsquo; Misuse: A Systematic Review on Antihistamines, Cough Medicines, and Decongestants. Frontiers in Psychiatry, 12, 657397. https://doi.org/10.3389/fpsyt.2021.657397 "},{"id":18,"href":"/docs/content/pharmacology/pharmacokinetics_introduction/","title":"Pharmacokinetics_introduction","section":"Pharmacology","content":"\rIntroduction to Pharmacokinetics\r#\rIntroduction\r#\rAs mentioned in the introduction, pharmacokinetics studies how the body interacts with drugs through absorption, distribution, metabolism, and elimination (ADME). Before we talk about each individually, there are a few fundamental concepts you should understand.\nThe Fluid Mosaic Model\r#\rWhen we talk about medications, it is really hard not to mention some fundamental concepts from cell biology and physiology. But don\u0026rsquo;t panic; they won\u0026rsquo;t be so hard to understand.\nJust like the skin that separates our internal organs from the external environment, the biological membrane is a layer of phospholipid bilayer that separates the content inside the cell from the content outside the cell.\nIn chemistry, there is a term called hydrophobic, which literally means \u0026ldquo;water-fearing,\u0026rdquo; and a term hydrophilic, which means \u0026ldquo;water-loving.\u0026rdquo; Interchangeably, lipophilic and lipophobic can also be used, and you guessed it, it literally means \u0026ldquo;lipid-loving\u0026rdquo; and \u0026ldquo;lipid-fearing.\u0026rdquo;\nPhospholipids are a type of amphipathic molecule (a molecule with both hydrophilic and hydrophobic regions) where one fatty acid from a triglyceride molecule is removed and replaced with a phosphate group (1 phosphate group, 2 fatty acids, and 1 glycerol).\nThe fluid mosaic model describes that these biological membranes are:\nSemi-permeable "},{"id":19,"href":"/about/","title":"About Piggy Botanist","section":"Welcome to My Website","content":"\rAbout Piggy Botanist:\r#\rMy name is Jeremy Chang, but you can call me Piggy Botanist.\nI earned my Bachelor of Science (BSc) with a major in Biomedical Science and a Master\u0026rsquo;s degree (MSc) specializing in Animal Science and Microbiology at the University of Guelph, where I studied from 2018 to 2023. I am currently pursuing a PhD in the Department of Computer Science at McGill University.\nI consider myself neither a complete biologist nor a full-fledged computer scientist; rather, I embody a unique intersection of both fields. This interdisciplinary background has granted me valuable experience in biological experiments within a wet lab environment, as well as in a traditional computer science lab focused on algorithm development, machine learning models, and software implementations. These experiences have equipped me with a solid foundation in bioinformatics, allowing me to bridge the gap between biology and computer science.\nDue to confidentiality, I cannot completely disclose my research project, but I am working on improving the process of metagenomics binning by utilize crowd-sourcing data in the training of AI agent. We hope to develop a bioinformatics analysis pipeline that enables the reconstruction of metagenomics assembled genome (MAG) for bacteria, fungi, protists, and virus from metagenomics samples collected from different enviornments which can include soil, fecal samples, fresh water, and environmental swabs.\nExperience:\r#\rPublications:\r#\rQi, N., Zhan, X., Milmine, J., Chang, K.-H., \u0026amp; Li, J. (2024). A novel thermophilic strain of Bacillus subtilis with antimicrobial activity and its potential application in solid-state fermentation of soybean meal. Microbiology spectrum, 12(4), e0278423. https://doi.org/10.1128/spectrum.02784-23\nQi, N., Zhan, X., Milmine, J., Sahar, M., Chang, K. H., \u0026amp; Li, J. (2023). Isolation and characterization of a novel hydrolase-producing probiotic Bacillus licheniformis and its application in the fermentation of soybean meal. Frontiers in nutrition, 10, 1123422. https://doi.org/10.3389/fnut.2023.1123422\n"}]